Tuesday, April 01, 2025

Reality Check: RFK Jr is a nut, promoting fringe conspiracy theories and medical quackery


Health and Human Services Secretary Robert F. Kennedy Jr., an anti-vaccine crusader, is not qualified to have any power at the agency that’s supposed to protect the health of Americans, said research analysts at Cantor Fitzgerald, which was formerly headed by Commerce Secretary Howard Lutnick.

Cantor’s note came as Peter Marks, the head of the Food and Drug Administration’s biologics division, resigned in protest of Kennedy’s skepticism of vaccines. Kennedy has already taken steps that public health experts say could deter routine immunizations in the U.S.

“We call on the administration to re-evaluate RFK Jr’s role at HHS. Pushing out one of the most trusted leaders of the FDA to promote an anti-science agenda is a step too far for us,” analysts Josh Schimmer and Eric Schmidt wrote in an unusual note to clients Tuesday. “HHS cannot be led by an anti-vax, conspiracy theorist with inadequate training.”

Kennedy has downplayed the importance of the measles, mumps and rubella vaccine and promoted unproven treatments to counter a measles outbreak. The Centers for Disease Control and Prevention is also carrying out a study into long-debunked links between vaccines and autism, led by a researcher with a history of spreading misinformation about shots.

Read the rest here.

EU Prepares Retaliation for Trump Tariffs

...“We will approach these negotiations from a position of strength,” European Commission President Ursula von der Leyen said in a speech to the European Parliament on Tuesday, the eve of Trump’s big tariff announcement.

“Europe holds a lot of cards. From trade to technology, to the size of our market. But this strength is also built on our readiness to take firm countermeasures. All instruments are on the table.”

In targeting U.S. services, Brussels could be thinking of bulge-bracket banks like J.P. Morgan or Bank of America, or tech players like Elon Musk’s social network X, search giant Google, or Amazon, the world’s largest online retailer.

“We are certainly not excluding a bigger response, a better response and an even more creative response through services, through [intellectual property rights],” a senior European Union official told reporters in mid-March.

The EU is a net exporter of automobiles, pharmaceuticals and food to the U.S. But it’s a net importer of services — and that gives it more leverage in a trade dispute. (Taking goods and services together, transatlantic trade is actually broadly in balance. The EU enjoys an overall surplus of just $50 billion, or about 3 percent of the $1.7 trillion in annual transatlantic commerce.)

“America’s tech giants, financial industry, and pharma companies have deep roots in Europe. Push too far, and Brussels could tighten the screws: digital levies on Silicon Valley, regulatory clamps on Wall Street, or taxes on U.S. pharma exports,” said Tobias Gehrke, a senior policy fellow at the European Council on Foreign Relations. 

“America may wield the bigger stick, but Europe has plenty of sharp stones to throw.”

Read the rest here.